type full_text Discharge Instruction x 0 D Functional status x 0 D PT: mobility limited by reduced exercise tolerance. prior to admission was able to mobilise 2 blocks, now only tolerates 40 m due to SOB. advised will need supervision for safety. otherwise good safety awareness. (no falls in last year) x 0 D OT: patient limited by reduced exercise tolerance and reduced standing balance but otherwise likely near baseline x 0 D x 0 D Changes to medications: x 0 D Lovastatin ceased due to mild LFT derangement x 0 D Reduced dose of losartan and amlodipine x 0 D Ceased hydralazine, ceased calcium vit D (nil falls in last 2 years, vit D replete) x 0 D commenced on iron replacement x 0 D x 0 D Discharge plan: x 0 D TCU Resp Med 8 10 weeks x 0 D to repeat CXR on arrival x 0 D Vaccinations (influenza and pneumococcal) x 0 D Complete course of PO antibiotics x 0 D DRC referral made for ongoing rehab in community patient is fit for rehab as tolerated x 0 D TCU OPS 1 2 weeks with memo to review RP (potassium levels), BP, Hb and iron levels x 0 D x 0 D Histopath Results nil Imaging Results see above Other Results see above Past Medical History see below Physical Examination 94 yo F x 0 D From home with daughter who is her primary carer x 0 D I ADLs with min assist x 0 D Ambulant in community with walking stick (up to 2 blocks) x 0 D x 0 D PMHx: x 0 D HTN x 0 D HLD x 0 D IHD x 0 D COPD not on regular puffers, no previous admissions x 0 D CVA x 2 ( 62 20 years ago, and 8 years ago) x 0 D Gout x 0 D Anaemia secondary to folate deficiency x 0 D BPPV x 0 D GERD x 0 D x 0 D Last admission Feb 2016 TTSH for x 0 D 1) unwitnessed fall void deck cx cerivcal spondylosis with stenosis, managed conservatively, and R 5 th MCP base closed, undisplaced , was in wrist splint x 0 D x 0 D This admission: x 0 D 1 week of productive cough with white yellow sputum x 0 D Intermittent SOB for last 1/12 x 0 D SOB worsening in the last 3 days x 0 D Went to GP who gave her SABA puffer but no improvement, no Abx started, hence came to hospital x 0 D Denies fever or other infective symptoms x 0 D x 0 D In ED x 0 D T afebrile x 0 D HR 87 x 0 D BP 175/69 x 0 D RR 18 x 0 D Sats 95 on room air x 0 D x 0 D JVP elevated x 0 D Hs 1 s 2 x 0 D Bilateral wheeze on L lung field x 0 D A SNT x 0 D Moving all 4 limbs x 0 D C supple no oedema x 0 D x 0 D ix x 0 D TW 8.13, Hb 10.6, Plts 240 x 0 D Neuts 6.37 x 0 D Na 136, K 5.4 (haemolysed) 62 3.6 x 0 D Ca 2.09 x 0 D Mg and P ok x 0 D x 0 D ALR 84 x 0 D AST 75 x 0 D GGT 119 x 0 D ALP 73 x 0 D Trop 27.7 x 0 D CRP 7.5 x 0 D x 0 D ECG SR,some P wave inversion in II, III, aVF, no ST changes x 0 D x 0 D CXR Loculated gas lucency projected over the left lower zone is again demonstrated, may be related to eventration of the left hemidiaphragm with presence of bowel loop inferiorly. Adjacent atelectatic changes are seen in the left lower zone. No confluent lung consolidation is noted. Mild blunting of the right costophrenic angle may be related to a small pleural effusion. x 0 D x 0 D Imp: exacerbation of COPD x 0 D Given nebs x 3 and PO pred in ED x 0 D x 0 D Issues this admission x 0 D 1) non infective exacerbation of COPD (first admission) with new pulmonary hypertension and secondary TR x 0 D Commenced on PO pred and seretide inhalers 125/25 2 puffs BD, with regular salbutamol nebs x 0 D However on 2 nd day required escalation of therapy to IV hydrocortisone and salbutamol/atrovent nebs x 0 D Patient improved with this treatment and these were slowly weaned off x 0 D x 0 D With regards to her COPD hx x 0 D apparently long standing diagnosis but only ever treated in polyclinc/GP with ventolin and berodual puffers this was ceased 2013 as patient was well and deemed stable from lung point of view, nil previous admissions for SOB/exacerbation x 0 D triggers that they stated were from concurrent infection (but never complained of SOB, only a chronic cough with white sticky sputum), or change in temperature (cold) x 0 D chronic cough for years with white sticky sputum x 0 D when unwell with cold, only received antibiotics and occasionally ventolin x 0 D smoking history: used to smoke since young, self rolled cigarettes, unable to quantify but defnintely much less frequent over the years, only fully stopped 3 4 years ago x 0 D Exercise tolerance usually up to 2 blocks of walking (where coffee shop is), can't go further because tired, not due to SOB. SOB only on exertion (when she starts sweating) x 0 D x 0 D This admission was noted to have a raised JVP to angle of jaw which prompted investigation with 2 DE to assess cardiac function. x 0 D 2 DE PASP 54 mmhg. dilated atria. Normal LV/RV systolic function. No RWMA at rest. Diastolic dysfunction Grade 2. Concentric left ventricular remodeling. Aortic valve sclerosis without stenosis. Mitral valve regurgitation mild. Mitral annular calcification. Tricuspid valve regurgitation severe. Pulmonary hypertension. x 0 D x 0 D We also did a HRCT to assess cause of this pulm HTN. This showed x 0 D Mild centrilobular emphysema. Moderate right and mild left pleural effusion with bibasilar atelectasis. Septal thickening in the upper lungs probably representing congestive changes. Possibility of the bronchial malacia in bilateral lower lobe bronchi. However, this was not assessed in the scan as the patient was not able to hold the breath. x 0 D x 0 D BNP 1433 x 0 D x 0 D 2) Bilateral pleural effusions x 0 D Seen by Resp who advised Spirometry pre post seretide 62 inaccurate results x 0 D Also fluid restricted to 1 L and CXR repeated (see point 3) x 0 D Patient also given small dose of frusemide 20 mg for trial of diuresis, with K replacement (noted hypokalemia, see point 7) x 0 D Decision made to stop frusemide as patient able to stick to strict fluid restriction and persistent hypokalemia with low dose frusemide x 0 D Clinically, effusions improved x 0 D For repeat CXR when follow up with RCCM x 0 D x 0 D 3) HAP x 0 D On repeat CXR noted new changes of consolidation on RLZ and L pleural effusion x 0 D Clinically patient was not haemodynamically unstable but had ongoing SOB particularly with eating x 0 D As per resp advice commenced on IV augmentin and PO cipro for HAP x 0 D This was escalated to IV tazocin due to patient spiking a temp x 0 D De escalated to PO augmentin once afebrile for 48 hrs x 0 D To complete 7/7 course of antibiotics x 0 D x 0 D 4) LFT derangement hepatocellular x 0 D Noted mild LFT derangement as above x 0 D Statin withheld x 0 D these remained stable and clinically patient didn't have any R upper quadrant pain or clinical findings of liver disease x 0 D nil history of alcoholism or previous liver infections x 0 D Hep B and C screen negative x 0 D decision made not to pursue further investigations at this stage x 0 D x 0 D 5) Microcytic hypochromic anaemia with mild early Fe deficiency x 0 D Noted Hb lower than previous tests and history of macrocytic anemia secondary to previous folate deficiency x 0 D Anemia panels repeated x 0 D Folate 13 x 0 D B 12 506 x 0 D Iron 9.4 x 0 D Ferritin 50 x 0 D Transferrin 176 x 0 D TIBC 46 x 0 D Iron sats 20 x 0 D likely mild early Fe deficiency x 0 D commenced on low dose iron replacement for follow up in OPS (monitor Hb and iron levels) x 0 D x 0 D 6) Trop T elevation likely 2' to leak x 0 D given no clinical chest pain or ECG changes, this was not repeated x 0 D x 0 D 7) Hypokalemia x 0 D Noted to have spurious high reading of K initially secondary to gross hemolysis x 0 D On repeat bloods initially stable, then noted to have lower readings x 0 D Given oral replacement, but when commenced diuresis, developed K 2.7 62 given IV and PO replacement x 0 D ECG atrial ectopics x 0 D K 3.2 on discharge with 1 more day of oral replacement x 0 D to follow up in OPS to check RP x 0 D x 0 D 8) R wrist swelling x 0 D Pt c/o pain to R wrist after trauma (she couldn't tell us what she hit, nurses didn't observe) x 0 D localised swelling and tenderness x 0 D XR no fracture x 0 D topical ketoprofen gel for analgesia with good effect and pain and swelling resolved x 0 D likely local soft tissue injury x 0 D x 0 D 9) Occasional Hypertension x 0 D noted high BP readings up to 190 1 2 times, patient asymptomatic x 0 D given frusemide whilst in hospital as aiming for diuresis of pleural effusions as above but this was not continued on dc x 0 D BP otherwise stable x 0 D hydralazine ceased, losartan dose reduced and amlodipine dose reduced x 0 D x 0 D 10) EOL status x 0 D given that this was her first admission for COPD exacerbation, and given patient pre morbidly well, this was discussed with patient and family x 0 D Patient and family are firm and clear that patient does not want CPR in view of poor success rates and high risk of rib fractures, brain hypoxic injury x 0 D However, patient and family are keen for trial of ICU for intubation if she becomes unwell with respiratory failure secondary to her acute illness x 0 D ACP was not filled out this admission due to conflict of interest between DNR and still for ICU for intubation and resp failure x 0 D x 0 D 10) Other things to note: x 0 D (a) screening tests NAD x 0 D Vit D 43.2 x 0 D T 4 15.8 x 0 D TSH 2.61 x 0 D HbA 1 c 4.4 x 0 D (b) Vaccinations x 0 D would benefit from influenza and pneumococcal vaccines x 0 D will include this in memo to RCCM to administer on follow up x 0 D x 0 D Functional status x 0 D PT: mobility limited by reduced exercise tolerance. prior to admission was able to mobilise 2 blocks, now only tolerates 40 m due to SOB. advised will need supervision for safety. otherwise good safety awareness. (no falls in last year) x 0 D OT: patient limited by reduced exercise tolerance and reduced standing balance but otherwise likely near baseline x 0 D x 0 D Changes to medications: x 0 D Lovastatin ceased due to mild LFT derangement x 0 D Reduced dose of losartan and amlodipine x 0 D Ceased hydralazine, ceased calcium vit D (nil falls in last 2 years, vit D replete) x 0 D commenced on iron replacement x 0 D x 0 D Discharge plan: x 0 D TCU Resp Med 8 10 weeks x 0 D to repeat CXR on arrival x 0 D Vaccinations (influenza and pneumococcal) x 0 D Complete course of PO antibiotics x 0 D DRC referral made for ongoing rehab in community patient is fit for rehab as tolerated x 0 D TCU OPS 1 2 weeks with memo to review RP (potassium levels), BP, Hb and iron levels x 0 D Ordered Medication amLODIPine TABLET nbsp nbsp nbsp nbsp nbsp DOSE: 5 mg OM PO/Tube START: 08 Mar 2019 17:37 >>> FOR 60 Days decreased dose nbsp nbsp nbsp nbsp nbsp [REDACTED], [REDACTED] [REDACTED][REDACTED] / [REDACTED_NUMBER] Gamoxicillin 500 mg clavulanic acid 125 mg AUGMENTIN TABLET nbsp nbsp nbsp nbsp nbsp DOSE: 625 mg BD after food PO/Tube START: 08 Mar 2019 17:37 >>> FOR 1 Days nbsp nbsp nbsp nbsp nbsp [REDACTED], [REDACTED] [REDACTED][REDACTED] / [REDACTED_NUMBER] Gclopidogrel TABLET nbsp nbsp nbsp nbsp nbsp DOSE: 75 mg OM PO/Tube START: 08 Mar 2019 17:37 >>> FOR 60 Days nbsp nbsp nbsp nbsp nbsp [REDACTED], [REDACTED] [REDACTED][REDACTED] / [REDACTED_NUMBER] Gferrous GLUCONATE SANGOBION CAPSULE nbsp nbsp nbsp nbsp nbsp DOSE: 1 capsule(s) OM before food PO/Tube START: 08 Mar 2019 17:37 >>> FOR 60 Days nbsp nbsp nbsp nbsp nbsp [REDACTED], [REDACTED] [REDACTED][REDACTED] / [REDACTED_NUMBER] Gglyceryl trinitrate TABLET nbsp nbsp nbsp nbsp nbsp DOSE: 500 mcg TDS PRN for chest pain SL (SubLingual) START: 08 Mar 2019 17:37 >>> FOR 60 Days nbsp nbsp nbsp nbsp nbsp [REDACTED], [REDACTED] [REDACTED][REDACTED] / [REDACTED_NUMBER] Ghypromellose EYE DROP nbsp nbsp nbsp nbsp nbsp DOSE: 1 drop(s) BD PRN for dry eyes Ophthalmic START: 08 Mar 2019 17:37 >>> FOR 60 Days APPLY: To Both eyes nbsp nbsp nbsp nbsp nbsp [REDACTED], [REDACTED] [REDACTED][REDACTED] / [REDACTED_NUMBER] Gisosorbide DInitrate TABLET nbsp nbsp nbsp nbsp nbsp DOSE: 5 mg TDS before food PO/Tube START: 08 Mar 2019 17:37 >>> FOR 60 Days nbsp nbsp nbsp nbsp nbsp [REDACTED], [REDACTED] [REDACTED][REDACTED] / [REDACTED_NUMBER] Glactulose SYRUP nbsp nbsp nbsp nbsp nbsp DOSE: 10 mL BD PO/Tube START: 08 Mar 2019 17:37 >>> FOR 60 Days nbsp nbsp nbsp nbsp nbsp [REDACTED], [REDACTED] [REDACTED][REDACTED] / [REDACTED_NUMBER] Glosartan TABLET nbsp nbsp nbsp nbsp nbsp DOSE: 50 mg OM PO/Tube START: 08 Mar 2019 17:37 >>> FOR 60 Days decreased dose nbsp nbsp nbsp nbsp nbsp [REDACTED], [REDACTED] [REDACTED][REDACTED] / [REDACTED_NUMBER] GOMEprazole CAPSULE nbsp nbsp nbsp nbsp nbsp DOSE: 40 mg OM before food PO START: 08 Mar 2019 17:37 >>> FOR 60 Days nbsp nbsp nbsp nbsp nbsp [REDACTED], [REDACTED] [REDACTED][REDACTED] / [REDACTED_NUMBER] Gparacetamol TABLET nbsp nbsp nbsp nbsp nbsp DOSE: 1000 mg TDS PRN for Pain or Fever PO/Tube START: 08 Mar 2019 17:37 >>> FOR 60 Days nbsp nbsp nbsp nbsp nbsp [REDACTED], [REDACTED] [REDACTED][REDACTED] / [REDACTED_NUMBER] Gpotassium CHLORIDE SR TABLET nbsp nbsp nbsp nbsp nbsp DOSE: 1200 mg BD after food PO START: 08 Mar 2019 17:37 >>> FOR 1 Days nbsp nbsp nbsp nbsp nbsp [REDACTED], [REDACTED] [REDACTED][REDACTED] / [REDACTED_NUMBER] Gsalbutamol 100 mcg/puff INHALER nbsp nbsp nbsp nbsp nbsp DOSE: 2 puff(s) QDS PRN for as 1 st line for wheezing/SOB Inhalation START: 08 Mar 2019 17:37 >>> FOR 60 Days to use with spacer nbsp nbsp nbsp nbsp nbsp [REDACTED], [REDACTED] [REDACTED][REDACTED] / [REDACTED_NUMBER] Gsalmeterol 25 mcg fluticasone 125 mcg SERETIDE 25/125 EVOHALER nbsp nbsp nbsp nbsp nbsp DOSE: 2 puff(s) BD Inhalation START: 08 Mar 2019 17:37 >>> FOR 60 Days nbsp nbsp nbsp nbsp nbsp [REDACTED], [REDACTED] [REDACTED][REDACTED] / [REDACTED_NUMBER] Gsenna TABLET nbsp nbsp nbsp nbsp nbsp DOSE: 15 mg ON PO/Tube START: 08 Mar 2019 17:37 >>> FOR 60 Days nbsp nbsp nbsp nbsp nbsp [REDACTED], [REDACTED] [REDACTED][REDACTED] / [REDACTED_NUMBER] Gspace chamber standard DEVICE nbsp nbsp nbsp nbsp nbsp DOSE: 1 each Once Inhalation START: 08 Mar 2019 17:37 >>> FOR 1 Days nbsp nbsp nbsp nbsp nbsp [REDACTED], [REDACTED] [REDACTED][REDACTED] / [REDACTED_NUMBER] Gspace chamber FACE MASK SIZE 4 DEVICE nbsp nbsp nbsp nbsp nbsp DOSE: 1 each Once Inhalation START: 08 Mar 2019 17:37 >>> FOR 1 Days nbsp nbsp nbsp nbsp nbsp [REDACTED], [REDACTED] [REDACTED][REDACTED] / [REDACTED_ID 2]